Abstract
The stability of two purified monoclonal antibodies, MN12 and WT31, was investigated. The monoclonal antibodies were incubated for 32 days at different pH values (ranging from 3.0 to 10.0) at 4 and 37°C. Various analytical methods were used to assess changes in physicochemical properties of the proteins. The monoclonal antibodies were more susceptible to degradation at 37°C than at 4°C. At low pH irreversible precipitation occurred. Decomposition of the proteins was enhanced at increasing pH values in the alkaline range. This was concluded from mouse IgG-specific and antigen-specific enzyme-linked immunosorbent assays, flow cytometry, analytical gel permeation chromatography, sodium dodecyl sulfate–polyacrylamide gel electrophoresis, isoelectric focusing, and immunoblotting. No substantial change in the apparent affinity constant of MN12 was observed, as determined by an affinity enzyme-linked immunosorbent assay. Fluorescence spectra, fluorescence polarization values, and fluorescence quenching parameters of MN12 and WT31 were not substantially affected, indicating that no major irreversible conformational changes had occurred. It was concluded that each of the techniques used has only limited value for stability assessment of monoclonal antibodies and, hence, that the application of several analytical techniques is essential to gain insight into monoclonal antibody stability.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
R. Sherwood. Therapeutic proteins: the need for analysis. Trends Biotechnol. 6:135–136 (1988).
J. R. Robinson. Biological sciences and the future of pharmaceutics. Pharm. Technol. 12:57–62 (1988).
M. C. Manning, K. Patel, and R. T. Borchardt. Stability of protein Pharmaceuticals. Pharm. Res. 6:903–918 (1989).
Committee for Propriety Medicinal Products Ad Hoc Working Party on Biotechnology/Pharmacy. Guidelines on the production and quality control of medicinal products derived by recombinant DNA technology. Trends Biotechnol. 5:G1–G4 (1987).
P. A. Underwood and P. A. Bean. The influence of methods of production, purification and storage of monoclonal antibodies upon their observed specificities. J. Immunol. Methods 80:189–197 (1985).
C. Bruck, D. Portetelle, C. Glineur, and A. Bollen. One-step purification of mouse monoclonal antibodies from ascites fluid by DEAE Affi-Gel Blue chromatography. J. Immunol. Methods 53:313–319 (1982).
J. W. Goding. Monoclonal Antibodies: Principles and Practice, 2nd ed., Academic Press, London, 1986.
H. Abdillahi and J. T. Poolman. Class 1 OMP subtyping of meningococci. In J. T. Poolman and H. C. Zanen (eds.), Gonococci and Meningococci, Kluwer Academic, Dordrecht, 1988, pp. 5–10.
H. Spits, J. Borst, W. Tax, P. J. A. Capel, C. Terhorst, and J. E. De Vries. Characteristics of a monoclonal antibody (WT-31) that recognizes a common epitope on the human T cell receptor for antigen. J. Immunol. 135:1922–1928 (1985).
W. Jiskoot, J. J. C. C. Van Hertooij, J. W. T. M. Klein Gebbinck, T. Van der Velden-de Groot, D. J. A. Crommelin, and E. C. Beuvery. Two-step purification of a murine monoclonal antibody intended for therapeutic application in man. Optimisation of purification conditions and scaling up. J. Immunol. Methods 124:143–156 (1989).
W. Jiskoot, J. W. T. M. Klein Gebbinck, J. J. C. C. Van Hertrooij, T. Van der Velden-de Groot, D. J. A. Crommelin, and E. C. Beuvery. A purification strategy for the production of clinical grade monoclonal antibodies. Dev. Biol. Stand. 71:73–78 (1990).
J. D. Beatty, B. G. Beatty, and W. G. Vlahos. Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J. Immunol. Methods 100:173–179 (1987).
J. D. Beatty, B. G. Beatty, W. G. Vlahos, and A. R. Hill. Method of analysis of non-competitive enzyme immunoassays for antibody quantification. J. Immunol. Methods 100:161–172 (1987).
J. H. A. Boot, M. E. J. Geerts, and L. A. Aarden. Monoclonal anti-peroxidase isotype switch variants. Applications in studies of protein A binding and characterization of rat monoclonal antibodies. J. Immunol. Methods 103:69–77 (1987).
A. B. Schreiber, A. D. Strosberg, and I. Pecht. Fluorescence of tryptophan residues in homogeneous rabbit antibodies: Variability in quantum yields and degree of exposure to solvent. Immunochemistry 15:207–212 (1978).
K. L. Bentley, L. K. Thompson, R. J. Klebe, and P. M. Horowitz. Fluorescence polarization: A general method for measuring ligand binding and membrane viscosity. BioTechniques 3:356–366 (1985).
J. N. Herron and E. W. Voss, Jr. Characterization of fluorescent 2-dimethylaminonaphtalene-5-sulfonyl-immunoglobulin G conjugates for application in fluorescence polarization studies. J. Biochem. Biophys. Methods 5:1–17 (1981).
R. M. Watt and E. W. Voss, Jr. Solvent perturbation of the fluorescein bound to specific antibody. J. Biol. Chem. 254:1684–1690 (1979).
S. S. Lehrer. Solute perturbation of protein fluorescence. The quenching of the tryptophyl fluorescence of model compounds and of lysozyme by iodide ion. Biochemistry 10:3254–3263 (1971).
B. Friguet, A. F. Chaffonte, L. Djavadi-Ohaniance, and M. E. Goldberg. Measurements of the true affinity constants in solutions of antigen-antibody complexes by enzyme-linked immunosorbent assay. J. Immunol. Methods 77:305–319 (1985).
F. J. Stevens. Modification of an ELISA-based procedure for affinity determination: Correction for use with bivalent antibody. Mol. Immunol. 24:1055–1060 (1987).
P. J. Hogg, S. C. Johnston, M. R. Bowles, S. M. Pond, and D. J. Winzor. Evaluation of equilibrium constants for antigen-antibody interactions by solid-phase immunoassay: The binding of paraquat to its elicited mouse monoclonal antibody. Mol. Immunol. 24:797–801 (1987).
P. Parham. Preparation and purification of active fragments from mouse monoclonal antibodies. In D. M. Weir (ed.), Handbook of Experimental Immunology, Vol. 1, 4th ed., Blackwell Scientific, Oxford, 1986, pp. 14.1–14.23.
D. R. Hoffman. Studies of the structure and synthesis of immunoglobulins by isoelectric focusing. In N. Catsinpoolas and J. Drysdale (eds.), Biological and Biomedical Applications of Isoelectric Focusing, Plenum Press, New York, 1977, pp. 121–153.
R. G. Hamilton, C. B. Reimer, and L. S. Rodkey. Quality control of murine monoclonal antibodies using isoelectric focusing affinity immunoblot analysis. Hybridoma 6:205–217 (1987).
W. W. Young, Jr., Y. Tamura, D. M. Wolock, and J. W. Fox. Staphylococcal protein A binding to the Fab fragments of mouse monoclonal antibodies. J. Immunol. 133:3163–3166 (1984).
J. Hayrinen, D. Bitter-Suermann, and J. Finne. Interaction of meningococcal group B monoclonal antibody and its Fab fragment with α2-8-linked sialic acid polymers: Requirement of a long oligosaccharide segment for binding. Mol. Immunol. 26:523–529 (1989).
D. M. Jameson and G. D. Reinhart. Fluorescent Biomolecules: Methodologies and Applications, Plenum Press, New York, 1989.
J. S. Finlayson. Quality control of intravenous immunoglobulin preparations. In K. E. Nydegger (ed.), Immunotherapy. A Guide to Immunoglobulin Prophylaxis and Therapy, Academic Press, London, 1981, pp. 171–180.
G. Guencheva. Requirements and characteristics of various immunoglobulin preparations for intravenous application. Z. gesamte Hyg. Grenzgeb. 30:21–23 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jiskoot, W., Beuvery, E.C., de Koning, A.A.M. et al. Analytical Approaches to the Study of Monoclonal Antibody Stability. Pharm Res 7, 1234–1241 (1990). https://doi.org/10.1023/A:1015925519154
Issue Date:
DOI: https://doi.org/10.1023/A:1015925519154